ECSP077423A - Coadministración de tigeciclina y digoxin - Google Patents

Coadministración de tigeciclina y digoxin

Info

Publication number
ECSP077423A
ECSP077423A EC2007007423A ECSP077423A ECSP077423A EC SP077423 A ECSP077423 A EC SP077423A EC 2007007423 A EC2007007423 A EC 2007007423A EC SP077423 A ECSP077423 A EC SP077423A EC SP077423 A ECSP077423 A EC SP077423A
Authority
EC
Ecuador
Prior art keywords
digoxin
tigecicline
coadministration
tigecycline
administration
Prior art date
Application number
EC2007007423A
Other languages
English (en)
Inventor
Donald G Raible
Gopal Muralidharan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP077423A publication Critical patent/ECSP077423A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

La invención se relaciona con el tratamiento de infecciones bacterianas con tigeciclina y la insuficiencia cardiaca con digoxin mediante la coadministración a un humano que lo necesita.
EC2007007423A 2004-10-28 2007-04-27 Coadministración de tigeciclina y digoxin ECSP077423A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62285904P 2004-10-28 2004-10-28

Publications (1)

Publication Number Publication Date
ECSP077423A true ECSP077423A (es) 2007-05-30

Family

ID=36127476

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007423A ECSP077423A (es) 2004-10-28 2007-04-27 Coadministración de tigeciclina y digoxin

Country Status (18)

Country Link
US (1) US20060094668A1 (es)
EP (1) EP1804807B1 (es)
JP (1) JP2008518911A (es)
KR (1) KR20070069182A (es)
CN (1) CN101039679A (es)
AT (1) ATE415973T1 (es)
AU (1) AU2005310306A1 (es)
BR (1) BRPI0517406A (es)
CA (1) CA2582089A1 (es)
CR (1) CR9073A (es)
DE (1) DE602005011468D1 (es)
EC (1) ECSP077423A (es)
IL (1) IL182681A0 (es)
MX (1) MX2007005163A (es)
NO (1) NO20071706L (es)
RU (1) RU2007112409A (es)
WO (1) WO2006060084A2 (es)
ZA (1) ZA200703441B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102512429A (zh) 2005-03-14 2012-06-27 惠氏公司 替加环素组合物及制备方法
AR055336A1 (es) * 2005-06-16 2007-08-22 Wyeth Corp Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
US20100035845A1 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
MY199695A (en) 2017-01-27 2023-11-18 Neurocrine Biosciences Inc Methods for the administration of certain vmat2 inhibitors
DK3684333T3 (da) 2017-09-21 2025-05-12 Neurocrine Biosciences Inc Valbenazin-formulering med høj dosis og sammensætninger, fremgangsmåder og kits relateret hertil
US20200230127A1 (en) 2017-10-10 2020-07-23 Neurocrine Biosciences, Inc. Methods for the Administration of Certain VMAT2 Inhibitors

Also Published As

Publication number Publication date
WO2006060084A3 (en) 2006-07-20
NO20071706L (no) 2007-05-24
BRPI0517406A (pt) 2008-10-07
EP1804807A2 (en) 2007-07-11
ATE415973T1 (de) 2008-12-15
CR9073A (es) 2007-08-28
RU2007112409A (ru) 2008-12-10
US20060094668A1 (en) 2006-05-04
IL182681A0 (en) 2007-09-20
AU2005310306A1 (en) 2006-06-08
JP2008518911A (ja) 2008-06-05
EP1804807B1 (en) 2008-12-03
CA2582089A1 (en) 2006-06-08
DE602005011468D1 (de) 2009-01-15
KR20070069182A (ko) 2007-07-02
CN101039679A (zh) 2007-09-19
MX2007005163A (es) 2007-06-26
WO2006060084A2 (en) 2006-06-08
ZA200703441B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
CL2009001099A1 (es) Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune.
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
ECSP077423A (es) Coadministración de tigeciclina y digoxin
CL2008001855A1 (es) Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa.
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
AR109263A2 (es) Composición que comprende moxidectina
ECSP077340A (es) Nuevos derivados de pirimidina y su uso como moduladores del ppar-alfa
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
ECSP10010464A (es) Uso de ranolazina para el tratamiento de enfermedades cardiovasculares
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
UY29189A1 (es) Nonadepsipeptidos acilados ii
EA200602002A1 (ru) Применение спинозинов для заживления ран
EA201000864A1 (ru) Фенилоксетанильные производные
CL2008001613A1 (es) Compuestos macrociclicos; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
NO20080495L (no) PEG-IFN-alfa og ribavirin for HBV-behandling
EA200802136A1 (ru) Лечение меланомы
CL2010001589A1 (es) Compuestos derivados de 3-ciano-pirrolidin-fenil-oxazolidinonas; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.
CL2011001399A1 (es) Compuestos derivados de morfina-6-glucuronido; medicamento; composicion farmaceutica que los comprende; compuestos intermediarios; y su uso en el tratamiento o prevencion del dolor.
UY28951A1 (es) Pequenas moleculas para el tratamiento de hipercolesterolemia y enfermedades relacionadas
CL2011001493A1 (es) Uso local de estriol para un medicamento util en la prevencion y/o el tratamiento de atrofia urogenital en mujeres.